SHERRY ALEKSICH: Open Payments
NPI 1114173523 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,517 in 86 payments from 19 companies in 2025. Trend: 2023 $9,779 · 2024 $5,492 · 2025 $6,517
Speaker / faculty: $4,375Food & beverage: $2,142
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $4,641 |
| Axsome Therapeutics, Inc. | 7 | $260 |
| Otsuka America Pharmaceutical, Inc. | 5 | $232 |
| Alkermes, Inc. | 7 | $214 |
| Janssen Pharmaceuticals, Inc | 3 | $183 |
| Lundbeck LLC | 7 | $158 |
| Neurocrine BioSciences, Inc. | 3 | $154 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $146 |
| Tris Pharma Inc | 7 | $115 |
| Corium, LLC | 5 | $106 |
Products named: VRAYLAR, Auvelity, REXULTI, ABILIFY ASIMTUFII, ARISTADA, SPRAVATO, INGREZZA, CAPLYTA.
Industry payments across WI — which companies pay providers there.
